Document is current
Any future updates will be listed below
-
Authors
Enge, Katrine
Ulimoen, Sara Reinvik
Enger, Steve
Onarheim, Sophia
Olufsen, Mona
Pripp, Are Hugo
Steinsvik, Trude
Hall, Christian
Hetland, Mathias
Tveit, Arnljot
-
Funding
Funding for this research was provided by:
Vestre Viken Hospital Trust
- License Information
-
More Information
Article History
Received: 25 October 2024
Accepted: 14 February 2025
First Online: 14 March 2025
Declarations
:
: The RATAF II trial was approved by the Norwegian Medicines Agency and the Regional Ethics Committee (2015/1302). The trial was registered at (NCT02695992). Each patient gave informed consent in agreement with the Helsinki Declaration before participating in any study-related activity.
: Not applicable.
: The authors declare no competing interests.
